Trial Search Results

Blood Loss Measurement During Cesarean Delivery

The aim of this study is to assess the ability of the Triton Device to measure blood loss among women undergoing elective and non-elective cesarean delivery. This patient population often experiences significant blood loss during surgery, and measurements of surgical blood loss are often inaccurate.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Alex James Butwick

Stanford Investigator(s):


Inclusion Criteria:

   - American Society of Anesthesiologists physical status class I-III

   - undergoing Cesarean delivery under neuraxial anesthesia

   - age between 18 and 50

   - gestational age greater than or equal to 37 completed weeks

   - all ethnicities

Exclusion Criteria:

   - contraindication for epidural or spinal analgesia (bleeding diathesis, neuropathy,
   severe scoliosis, local anesthetic allergy)

   - inability to adequately understand the consent form

Ages Eligible for Study

18 Years - 50 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting